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Introduction {#sec1}
============

In the rodent brain, the ventricular-subventricular zone (V-SVZ) is located along the walls of the brain lateral ventricles and new neurons are continuously generated throughout life ([@bib3], [@bib26], [@bib77], [@bib78]). A monolayer of ependymal cells lines the ventricle, and adjacent located neural stem cells (type B cells) undergo self-renewal before differentiating into intermediate rapidly dividing progenitors (type C cells), which then give rise to neuroblasts (type A cells) ([@bib59], [@bib58]). These neuroblasts, in turn, migrate in chains rostrally along the RMS into the olfactory bulb (OB). Here, they switch from tangential to radial migration to reach their final destination within the OB and differentiate into functional interneurons.

Newly generated OB interneurons play an important role in the formation and maintenance of olfactory circuits, and as a consequence control important behaviors such as social recognition, reproductive behavior (e.g., mate selection), and parental care ([@bib64], [@bib66], [@bib89], [@bib50], [@bib51], [@bib61]). Although sex hormones play a key role in the regulation of these behaviors ([@bib107], [@bib108], [@bib56], [@bib20], [@bib74], [@bib60]), only few studies have focused on the role of gonadal hormones and their receptors in neurogenesis in the V-SVZ, and subsequently in the regulation of olfactory circuits ([@bib70], [@bib17]). For hippocampal neurogenesis it has been shown that steroids such as estrogens play a key role both during development and in adulthood ([@bib92], [@bib6], [@bib29]). Studies that have addressed potential effects of estradiol (E2) on proliferation of cells in the rodent V-SVZ have reported that E2 increases the number of embryonic but not adult neural stem cells ([@bib12], [@bib95], [@bib65]). This holds true for rats and mice. Other experiments, in contrast, point to prolactin as being an essential player in stimulating neurogenesis in the V-SVZ ([@bib89], [@bib53]).

Potential E2 effects on olfactory neurogenesis and migration of neuroblasts from the V-SVZ to the OB would require estrogen receptors (ER). E2 classically signals via the two ERs, ERα and ERβ, which belong to the superfamily of nuclear steroid hormone receptors. These receptors function as hormone-inducible transcription factors and upon binding of E2 induce gene transactivation. It has been previously shown that ERα, but not ERβ, mRNA is expressed within the V-SVZ ([@bib44]). In contrast, within the OB of rats and mice, both ERs and aromatase, the enzyme that converts testosterone into estradiol, have been found to be expressed ([@bib41], [@bib42], [@bib43], [@bib95]).

In addition to the transcription factors ERα and ERβ, a G protein-coupled receptor (GPCR)-30 (GPR30) was shown to mediate rapid or "pregenomic" effects of estrogen, events that occur within minutes after ligand exposure. The receptor was therefore named *G protein-coupled ER* (GPER)-1 ([@bib30], [@bib83], [@bib93]). GPER1 has a high affinity to estrogens and is localized either in the plasma membrane or in the endoplasmic reticulum ([@bib81]). To date no information is available for a possible role of GPER1 signaling in the V-SVZ in respect to E2 functions. In this study, we therefore analyzed the expression of GPER1 and ERα and show that GPER1 is expressed in specific cells of the V-SVZ of adult and P6 female mice. To be on the safe side, we used female animals only, as with respect to synaptic plasticity, estrogenic effects in the brain have frequently been shown to differ in the hippocampus of males and females ([@bib14], [@bib13], [@bib96]). In this study, we provide evidence for a role of GPER1 in the control of neuroblast migration. Moreover, we identify Ras-mediated signaling mechanisms and p21-dependent modulation of cofilin as being crucial in GPER1-mediated regulation of neuroblast migration.

Results {#sec2}
=======

To date our knowledge on the role of ERs in the modulation of processes within the V-SVZ is still elusive. In particular, nothing is known about the expression and localization of the recently described GPER1 in the V-SVZ and the adjacent RMS. Therefore, we analyzed the expression of GPER1, using fluorescence-based immunohistochemical analysis to detect the ER expression in adult female brains and in particular in brains of female P6 animals. We also analyzed ERα, whose mRNA in contrast to that of ERβ was found in the V-SVZ. The immunohistochemical data of the P6 animals were compared with data from Matrigel cultures, which were generated on P4-P5 and cultivated for 24 h.

Cell-Specific GPER1 Expression in the V-SVZ of Early Postnatal and Adult Mice {#sec2.1}
-----------------------------------------------------------------------------

In the case of GPER1 we took advantage of a polyclonal antiserum generated in rabbit, which was raised against a synthetic C-terminal peptide of GPER1 and that has previously been used for immunohistochemistry in various tissues including mouse brain tissue ([@bib11], [@bib27], [@bib88], [@bib54], [@bib101], [@bib104], [@bib47]). The specificity of the antibody has been verified in different independent studies including controls in a GPER-negative cell line and in shGPER-1 knockdown tissue ([@bib27], [@bib88], [@bib54]). Another antibody raised in goat that is also directed against a synthetic C-terminal peptide of GPER1 was used for control purposes. GPER1 was previously described to be localized at the membrane and/or in the cytoplasm, where its localization was postulated to be restricted to the endoplasmic reticulum ([@bib83], [@bib34]; for review see [@bib31]). Importantly, upon ligand binding, the receptor is internalized before degradation, which may explain that the receptor is commonly detected intracellularly ([@bib19]). In cells of the V-SVZ of early postnatal mice and in cells of adult mice GPER1 was abundantly expressed ([Figures 1](#fig1){ref-type="fig"}A--1C and [S1](#mmc1){ref-type="supplementary-material"}A). Colabeling of the two GPER1 antibodies revealed an identical labeling pattern, which underscores the specificity of our antibodies ([Figures 1](#fig1){ref-type="fig"}D and 1E). On the cellular level, we found GPER1 immunoreactivity surrounding the cell bodies and also occasionally in cellular processes (cell bodies: [Figure 1](#fig1){ref-type="fig"}E; arrowhead in [Figures 1](#fig1){ref-type="fig"}G and 1H; processes: [Figures 1](#fig1){ref-type="fig"}F and arrows in 1G). Interestingly, in many cases a clear asymmetric distribution of immunoreactivity was seen in GPER1-positive cells, with stronger labeling on one side of the cell body (arrows in [Figure 1](#fig1){ref-type="fig"}E).Figure 1GPER1 is Expressed in the Postnatal and Adult V-SVZ(A) Low-magnification fluorescence image with DAPI labeling, showing the SVZ (arrowheads) and the RMS (dotted lines) in a sagittal vibratome section of an adult female mouse brain.(B) Low-magnification confocal image of GPER1 (rb) expression in a P6 female brain section. GPER1 is expressed already at P6 in the neurogenic niche. The dotted line represents the border separating the lateral ventricle from the V-SVZ area.(C) Low-magnification images of 7-μm-thick paraffin sections of an adult female mouse brain, showing GPER1 (rb) expression in the V-SVZ next to the lateral ventricle. The dotted line represents the border separating the ventricle from the V-SVZ area.(D) Low-magnification pictures of rabbit- and goat-derived antibody immunohistochemistry of GPER1 taken from adult female mouse brain vibratome sections. Note that both antibodies label the same population of cells, although the staining intensity differs slightly.(E) High-magnification image of GPER1 (rb and gt)-positive cells from adult female V-SVZ showing colabeling of both antibodies. Of note immunoreactivity is mostly restricted (highest intensity) to one side of the cell (arrows).(F) Low-magnification fluorescence image showing GPER1 expression in the V-SVZ. (G) Higher magnification shows that in some cases, GPER immunohistochemistry revealed labeled processes of cells (arrows). (G and higher-magnification image in H) GPER1 expression is also seen in the cytoplasm surrounding (marked by arrowheads) the nucleus. LV, lateral ventricle; RMS, rostral migratory stream; SVZ, subventricular zone; gt, goat antibody; rb, rabbit antibody. Scale bars: 500 μm in (A), 10 μm in (D), 5 μm in (E), 20 μm in (F), and 5 μm in (G and H).

The expression of GPER1 in many, but not all, cells of the V-SVZ tempted us to define the cell type in the stem cell niche that expresses GPER1. The lineage of cells within the V-SVZ comprises type B1 and B2 astrocytes, transient amplifying progenitor cells (type C cells), and neuroblasts (type A cells) ([@bib26], [@bib33]).

Type B and type C cells are visualized by their expression of the transcription factor SOX2 ([@bib62]), and we found many GPER1/SOX2 double-positive cells in P6, as well as in adult animals ([Figures 2](#fig2){ref-type="fig"}A and [3](#fig3){ref-type="fig"}A). To identify whether GPER1 is expressed in type B cells we performed double-labeling using anti-GFAP and anti-Vimentin, both being markers of type B astrocytes ([@bib62]). Both markers are expressed in P6 and adult animals. We found GPER1/GFAP-positive ([Figure 2](#fig2){ref-type="fig"}B) as well as GPER1/Vimentin-positive cells ([Figure 3](#fig3){ref-type="fig"}B), which demonstrates that GPER1 is indeed expressed in type B cells in P6 and adult animals. A few cells expressed GPER1 but did not show labeling of GFAP or Vimentin (see arrowheads in [Figure 3](#fig3){ref-type="fig"}B). To test whether these cells represent type C cells, we used an antibody against epidermal growth factor receptor, a marker of transiently dividing C cells ([@bib62]). We found co-expression of GPER1 and EGFR in some cells of P6 animals ([Figure 2](#fig2){ref-type="fig"}C), whereas only very few and very weakly stained cells were seen in the adult stem cell niche ([Figure 3](#fig3){ref-type="fig"}C).Figure 2GPER1 is Expressed by Different Cell Types in the V-SVZ of Early Postnatal MiceConfocal images of 7-μm-thick paraffin sections showing double immunofluorescence in the V-SVZ of P6 female mice to demonstrate expression of GPER1 in different cell types within the stem cell niche. (A~1~) SOX2 is used as a marker for type B and type C cells. Merged image illustrates colabeling of SOX2 (rb) and GPER1 (gt). (A~2~) Higher magnification showing GPER1 immunoreactivity surrounding nuclear labeling of SOX2. (B~1~) Type B cells, identified by their expression of GFAP, also express GPER1. Merged images and higher-power magnification in (B~2~) reveal cells coexpressing GFAP (rb) and GPER1 (gt). (C~1~ and higher-magnification image in C~2~) GPER1 (gt) is also expressed in EGFR-positive type C cells (rb). All arrows point to cells displaying colocalization. gt, goat antibody; rb, rabbit antibody. Scale bars, 10 μm.Figure 3GPER1 is Expressed by Different Cell Types in the V-SVZ of Adult MiceFluorescence images of 7-μm-thick paraffin sections showing double immunofluorescence in the V-SVZ of adult female mice to demonstrate expression of GPER1 in the different cell types of the stem cell niche.(A) As in P6 animals, GPER1 immunohistochemistry (gt) in adult animals shows colabeling with SOX2 (rb) as a marker for type B and type C cells.(B) GPER1 (gt) also colocalizes with Vimentin (rb), a marker for type B cells. Note that not every cell expressing GPER1 is also positive for Vimentin (see arrowheads).(C) GPER1 (gt) shows weak coexpression with EGFR (rb), a marker for type C cells. Merged images illustrate colocalization. gt, goat antibody; rb, rabbit antibody. Scale bars, 20 μm.

The microtubule-associated protein Doublecortin (DCX) is an established marker for type A neuroblasts ([@bib62]). Double-labeling with antibodies against DCX and GPER1 revealed that in P6 animals GPER1-positive cells were occasionally also positive of DCX and thus identified as type A neuroblasts ([Figures 4](#fig4){ref-type="fig"}A and 4B). Apart from a small area at the beginning of the RMS, the neuroblasts in the RMS were devoid of any GPER1 immunolabeling ([Figure 4](#fig4){ref-type="fig"}C).Figure 4GPER1 and ERα Show a Different Expression Pattern in DCX-Positive Neuroblasts(A and higher-magnification image in B) Fluorescence images of 7-μm-thick paraffin sections showing double immunofluorescence in the V-SVZ of P6 female mice to demonstrate colocalization of GPER1 (rb) with DCX (gt) in type A neuroblasts. The higher magnifications show that GPER1 is expressed in DCX-positive cells in the V-SVZ. The arrowheads point to cells displaying colocalization. Note that GPER1 often shows a polarized distribution at the cell membrane (arrowheads).(C) Double immunofluorescence confocal images showing GPER1 (rb) and DCX (gt) in the RMS of an adult female mouse, taken from 50-μm-thick vibratome sections. Note that although GPER1 and DCX immunoreactivity is closely associated, DCX-expressing cells are not positive for GPER1.(D and higher-magnification image in E) Confocal images showing immunofluorescence with DCX (gt) and ERα (rb) in the RMS. Higher magnification demonstrating that ERα is expressed by DCX-positive neuroblasts. Arrowheads point to cells showing co-immunoreactivity. Few cells in the RMS express ERα but are negative for DCX (asterisks). LV, lateral ventricle; RMS, rostral migratory stream.Scale bars: 50 μm in (A), 10 μm in (B), 15 μm in (C), 50 μm in (D) and 10 μm in (E).

As a result, we found GPER1 to be expressed by subsets of all cell types of the stem cell lineage (type B, type C, and type A cells) in the V-SVZ. It needs to be mentioned that not every cell expressing one of the marker molecules was also positive of GPER1, suggesting that only a subset of each cell type expresses the receptor. Importantly, whereas immunoreactivity of GPER1 was abundant in the V-SVZ, immunoreactivity of GPER1 was missing in type A cells in the RMS.

Estrogen Receptor ERα Expression in the V-SVZ and the RMS {#sec2.2}
---------------------------------------------------------

In addition to the expression of GPER1, we analyzed the localization of the classical genomic ERα in the V-SVZ and the RMS in adult and postnatal mice using immunohistochemistry. The specificity of the antibody was controlled by preadsorption with the immunizing peptide (see [Figure S1](#mmc1){ref-type="supplementary-material"}D and S1E). In earlier studies, it was shown that ERα is not only localized in the cytoplasm and/or in the nucleus ([@bib45], [@bib4]) but also in the plasma membrane ([@bib73], [@bib63], [@bib75], [@bib82]). In accordance with these previous descriptions, we found ERα immunoreactivity subcellularly localized in the cytoplasm/nucleus (higher magnification in [Figure S1](#mmc1){ref-type="supplementary-material"}D) and additionally within the plasma membrane ([Figures 4](#fig4){ref-type="fig"}D and 4E). ERα-positive cells were ubiquitously present within the V-SVZ and in the RMS of adult ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1D, and [Figures 4](#fig4){ref-type="fig"}D and 4E) and P6 animals ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Using co-immunohistochemistry with anti-DCX and anti-ERα, we found that ERα is present in migrating type A cells of the RMS (arrowheads in [Figure 4](#fig4){ref-type="fig"}E).

The strong expression of ERα in DCX-positive cells within the RMS together with strong abundance of the receptor in the V-SVZ, but the lack of GPER1 expression in neuroblasts of the RMS, indicates that estrogenic signaling in cells of the neurogenic niche differs from estrogenic signaling in the RMS.

Aromatase Is Expressed within the V-SVZ and in the RMS {#sec2.3}
------------------------------------------------------

In the last years it has become increasingly evident that locally synthesized estradiol rather than estradiol from peripheral sources influences cerebral function, for instance, neuronal migration, synaptogenesis, and axon outgrowth ([@bib102], [@bib100], [@bib49], [@bib86], [@bib79], [@bib80], [@bib99]). In an attempt to identify a potential source of estradiol for the estrogen receptors in the neurogenic niche and the RMS we analyzed the expression of aromatase, the final enzyme of the estradiol synthesis.

The specificity of the aromatase antibody was controlled by preadsorption with the immunizing peptide ([Figure S2](#mmc1){ref-type="supplementary-material"}A--S2C). We found strong expression of aromatase in the stem cell niche ([Figure 5](#fig5){ref-type="fig"}A) and within the RMS ([Figures 5](#fig5){ref-type="fig"}B and 5C). This was the case in adult and P6 animals (data not shown) as well. Performing triple labeling of aromatase, DCX (to label migrating type A neuroblasts), and GFAP (to label astrocytes), we observed no co-labeling of aromatase and migrating DCX-positive neuroblasts ([Figures 5](#fig5){ref-type="fig"}B and 5C). In contrast, we found colocalization of aromatase and GFAP in astrocytes surrounding the migrating neuroblasts ([Figure 5](#fig5){ref-type="fig"}B and higher magnification in [Figure 5](#fig5){ref-type="fig"}C). To further substantiate our finding that glial cells express aromatase we used S100β, another marker for astrocytes, and we also observed co-expression of GFAP and S100β ([Figure 5](#fig5){ref-type="fig"}D). This finding strongly suggested that astrocytes, forming the well-known tube-like structure that surrounds the migrating neuroblasts, might be a source of estradiol. Thus, astrocytes in the neurogenic niche and the RMS may provide the ligand for ER-mediated functions during migration.Figure 5Aromatase Is Expressed in the Stem Cell Niche and in the RMS(A) Fluorescence images of aromatase immunofluorescence taken from the V-SVZ of an adult female mouse demonstrating that aromatase is also expressed within the stem cell niche. The dotted line represents the border separating the ventricle from the V-SVZ area.(B) Confocal images of triple fluorescence in the RMS of an adult female mouse brain to analyze colocalization of aromatase (rb), GFAP (ms), and DCX (gp). Merged images show that aromatase is expressed in GFAP-positive astrocytes ensheathing the migrating neuroblasts. No expression is found in DCX-positive migrating neuroblasts.(C) Higher-magnification image of (B) showing the coexpression of aromatase and GFAP. Note that DCX-positive structures are negative for aromatase.(D) S100β is a glial-specific marker and is expressed primarily by astrocytes. Confocal images of double fluorescence in the RMS of an adult female mouse brain show that aromatase is expressed in S100β-positive cells. LV, lateral ventricle.Scale bars: 50 μm in (A), 20 μm in (B), and 10 μm in (C and D).

Blocking of GPER1 with G15 Resulted in Reduced Cellular Migration of V-SVZ-Derived Matrigel Explants {#sec2.4}
----------------------------------------------------------------------------------------------------

Upon our finding of abundant expression of GPER1 in cells of the V-SVZ and our findings that astrocytes of the V-SVZ and of the RMS are aromatase-positive cells and may serve as a local source of estrogens, we hypothesized that GPER1 is involved in starting migration of cells from the V-SVZ. To test this hypothesis, we performed Matrigel explant cultures of V-SVZ tissue and analyzed the migration of cells in the presence of the GPER1 signaling antagonist G15 ([@bib23]). We cultured the explants for 24 h in the presence or absence of G15 and monitored their migration. The analysis of migratory outgrowth from the explants was performed following the method of Dixon et al. ([@bib25]). Accordingly, we performed a semi-quantitative classification, ranking the explants into four grades depending on the number of chains outgrown from the explant: grade1 (less than 10 chains), grade 2 (10--50 chains), grade 3 (50--100 chains), and grade 4 (more than 100 chains) (see [Figure 6](#fig6){ref-type="fig"}A). All explants with chains were considered for analysis. In total, we analyzed 197 explants (control: n = 100; G15: n = 97) from 18 animals. It is of note in this context that every animal delivers explants that were either treated with G15 or taken as controls, thus each animal generated explants for both conditions. G15 clearly inhibited the outgrowth from the explants (see [Figure 6](#fig6){ref-type="fig"}B). Accordingly, following G15 treatment we observed a significant augmentation in the number of explants with lower grades (see [Figure 6](#fig6){ref-type="fig"}B).Figure 6Blocking of GPER1 with G15 Leads to a Decrease in Migration of V-SVZ-Derived Explants(A) Light microscopic images showing examples of explant grades.(B) Graph showing the relative fraction of control and G15-treated explants in each grade per animal. Bars show mean ± standard error. A repeated measures two-way ANOVA on ranks was performed on the relative fractions (treatment: DF = 17, F-value = 1.070, p = 0.315; grade: DF = 15, F-value = 11.972, p \< 0.001; interaction: DF = 15, F-value = 4.210, p = 0.024). Please note a significant difference (Scheffe post hoc test) when comparing the fraction of control with G15-treated explants in grade 1 (DF = 51, test-value = 2.91, p = 0.005) and grade 2 (DF = 51, test-value = 2.147, p = 0.036). No significant difference was found within grade 3 (DF = 51, test-value = 0.179, p = 0.858) and grade 4 (DF = 51, test-value = 0.5834, p = 0.562). Level of significance p \> 0.05 (n.s.), ∗∗p \< 0.01.

As the blockade of GPER1 obviously results in inhibition of migration our results strongly point to an involvement of GPER1 in the migration of V-SVZ-derived cells. It is very likely, that astrocytes in the RMS and V-SVZ provide the specific ligand estradiol.

Ras-Induced p21 Is Involved in GPER1 Signaling in V-SVZ Matrigel Cultures {#sec2.5}
-------------------------------------------------------------------------

GPCRs mediate their signals via GTP-binding proteins. In this respect, the Ras signal transduction pathway is known for being important for cell growth, cell differentiation, and cell motility ([@bib7]) and serves as a molecular shift to switch on/off cellular processes. To test whether GPER1 signaling in V-SVZ cultures is mediated via Ras (gene name nRas) we collected the tissue after migration for qPCR analysis and analyzed changes regarding the expression profiles of Ras ([Figure 7](#fig7){ref-type="fig"}A). The experiments revealed a significant reduction of nRas expression cultures treated with G15 when compared with the controls ([Figure 7](#fig7){ref-type="fig"}A). The findings indicate that under physiological conditions nRas may mediate GPER1 signaling in V-SVZ cultures, It has been shown that activation of Ras can lead to an increase of cytosolic p21, a cyclin-dependent kinase inhibitor ([@bib52], [@bib84]). GPER1 activation, in turn, is linked to an upregulation of p21 ([@bib18]). Besides its known function as a negative regulator of cell cycle, recent findings have demonstrated that p21 is also involved in the regulation of cell proliferation ([@bib9], [@bib109]), differentiation ([@bib24]), and control of the actin cytoskeleton and cell migration ([@bib10]). Given this background, we hypothesized whether p21 levels are also affected when inhibiting GPER1 signaling with G15 in our V-SVZ culture system. We, therefore, performed qPCR studies to analyze p21 levels of explant cultures treated with G15. Similar to the observed G15 effect on Ras expression we found a significant decrease in p21 expression after blocking GPER1 with G15 ([Figure 7](#fig7){ref-type="fig"}B). These results indicate that GPER1 signaling in V-SVZ explant cultures affects nRas and p21 expression levels, which may account for the effects observed in cultures treated with G15.Figure 7Blocking of GPER1 with G15 Leads to a Decrease in Expression of nRas and p21(A and B) Graph demonstrating the expression of nRas (A) and p21 (B) in control (white bars) and G15 (gray bars)-treated cultures. qPCR data show that incubation of V-SVZ-derived cultures with the GPER1 antagonist G15 leads to a significant reduction of nRas expression when compared with control cultures (Mann-Whitney U test: U = 16, n1 = n2 = 7, p = 0.021). Similar to the observed G15 effect on Ras expression we found a significant decrease in p21 expression after blocking GPER1 with G15 tissue (Mann-Whitney U test: U = 25, n1 = n2 = 5, p = 0.008). Every experiment was performed at least three times. PCR efficiency was 1.8472 for Hprt, 1.7431 for nRas, and 1.7263 for p21. Statistical evaluation was performed using the non-parametric Wilcoxon-Mann-Whitney test. Level of significance ∗∗p \< 0.01.

The Ratio of p-Cofilin/Cofilin Is Increased in Samples Treated with G15 {#sec2.6}
-----------------------------------------------------------------------

Once differentiating precursors of the V-SVZ are in the type A cell status, these neuroblasts start to migrate out of their germinal niche. Cell division, differentiation, and, in particular, migration are processes that are linked to changes of the cytoskeleton. Actin depolymerizing factor/cofilin family members are able to bind G-actin monomers and depolymerize actin filaments, a prerequisite for migration and chemotaxis of cells ([@bib67], [@bib39], [@bib36]). Recently, it was shown that p21 is involved in Ras-induced inhibition of the ROCK/LIMK/cofilin pathway ([@bib52]). As we observed Ras and p21 to be downregulated in response to G15 treatment in V-SVZ explants, these findings prompted us to analyze whether GPER1 inhibition also alters cofilin dynamics. As cofilin destabilizes the cytoskeleton, whereas the phosphorylated form of cofilin (p-cofilin) stabilizes it ([@bib67], [@bib39]), we examined explants by western blot analysis to determine the ratio of cofilin and p-cofilin in cultures treated with G15-treated and non-treated cultures. Consistent with our findings on Ras and p21 expression, we observed that G15-treated V-SVZ cultures showed a significant shift in the ratio of p-cofilin/cofilin toward higher p-cofilin levels. Thus, the dynamics of the cytoskeleton are impaired in cultures with a blocked GPER1 ([Figure 8](#fig8){ref-type="fig"}A \[representative bands from cofilin/p-cofilin western blots\] and [Figure 8](#fig8){ref-type="fig"}B; see [Figure S3](#mmc1){ref-type="supplementary-material"} for full immunoblots with all markers of molecular weight, showing that every antibody labels only one single band). To exclude the possibility that potential residues of Matrigel could alter our results we performed control western blots with Matrigel probes ([Figure 8](#fig8){ref-type="fig"}C).Figure 8Treatment of Explants with G15 Leads to an Increase in the Ratio of p-Cofilin/n-Cofilin and Influences the Expression of Regulators of Cofilin(A) Western blots showing the expression of cofilin and p-cofilin from control and samples treated with G15.(B and C) (B) Graph showing that incubation with G15 (gray bar) leads to an increase in ratio of p-cofilin/cofilin relative to α-tubulin (Mann-Whitney U test: U = 1, n1 = n2 = 5, p = 0.022). (C) Western blots showing as a control of the antibodies used that no bands were visible in pure Matrigel preparations.(D) Western blot showing expression of TESK1, a regulator of cofilin, which inactivates the molecule by phosphorylation, in control and G15-treated samples.(E) Graph showing that treatment from explants with G15 leads to a significant increase in TESK1 expression (Mann-Whitney U test: U = 0, n1 = n2 = 4, p = 0.030).(F) Western blots showing as a control of the TESK1 antibody used that no bands were visible in pure Matrigel preparation.(G) Western blot showing expression of chronophin in control and G15-treated samples.(H and I) (H) In contrast to the TESK1 expression, the expression of chronophin, a regulator of cofilin, which activates the molecule by de-phosphorylation, is not significantly altered (Mann-Whitney U test: U = 9 n1 = n2 = 5, p = 0.531). (I) Western blot showing as a control of the Chronophin antibody used that no bands were visible in pure Matrigel preparation.

To further substantiate our results we controlled our p-cofilin versus cofilin readout by analyzing Tesk1 and chronophin levels in our culture system. Both proteins are well-known regulators of cofilin with Tesk1 inactivating cofilin by phosphorylation ([@bib94]) and chronophin activating it by de-phosphorylation ([@bib37]). In accordance with our finding that G15 treatment results in an increase in the ratio of p-cofilin/cofilin we observed that G15 leads to an increase in Tesk1 expression ([Figures 8](#fig8){ref-type="fig"}D and 8E), whereas chronophin expression is not changed or only slightly reduced ([Figures 8](#fig8){ref-type="fig"}G and 8H; see [Figure S3](#mmc1){ref-type="supplementary-material"} for full immunoblots with all markers of molecular weight). No signal was seen in pure Matrigel controls ([Figures 8](#fig8){ref-type="fig"}F and 8I). As a result, our results show that blocking of GPER1 in V-SVZ cultures by G15 results in a decrease of Ras and p21 expression levels and accordingly an increase in the ratio of p-cofilin/cofilin, thereby stabilizing the cytoskeleton.

Discussion {#sec3}
==========

GPER1 Is Strongly Expressed by Cells in the V-SVZ {#sec3.1}
-------------------------------------------------

The mechanisms controlling neurogenesis, differentiation, and migration processes in the V-SVZ are not yet fully understood. Although it is generally accepted that steroids such as estrogens influence cell proliferation in the germinal region of the hippocampal dentate gyrus, their role as a modulator in the stem cell niche of the V-SVZ is so far controversial. It has been shown that estradiol can stimulate progenitor cell division in the V-SVZ of the embryonic neocortex ([@bib65]). Other studies, however, deny an involvement of estrogens in cell proliferation and point to prolactin as a player in the regulation of V-SVZ-derived progenitor fate ([@bib89]).

In this study, we demonstrate a novel role of GPER1 in the regulation of V-SVZ-derived neuroblast migration. For our experiments we used female animals only, as estrogenic actions in the brain have been shown to be sex specific (for review see [@bib13]). It was shown that in the hippocampus locally synthesized estradiol regulates dendritic spine and spine synapse density and long-term potentiation only in females but not in males ([@bib96]), whereas locally synthesized dihydrotestosterone regulates these parameters of synaptic plasticity in males but not in females ([@bib14]). Performing immunohistochemistry with markers labeling the different cell types within the V-SVZ we found GPER1 expression in all cell types of the stem cell niche in principal. However, not every cell expressing one of the marker molecules was also positive of GPER1, suggesting that only a subset of each cell type expresses the receptor. Recently, it was shown that type B astrocytes as well as type C cells and neuroblasts gain and lose their marker expression profile throughout their lineage progression ([@bib62]), showing that the expression pattern may overlap at the transition from one cell type to another. It is tempting, therefore, to speculate that GPER1 expression might be transient as well, depending on the developmental state of the cells. Along these lines, GPER1 often shows a polarized expression in the V-SVZ, in contrast to even staining of the cell membrane in non-dividing and differentiated cells. Polarized expression of receptors during migration has been proposed to enable cells to respond to gradients of chemical attractants ([@bib72], [@bib103]). For chemokine receptors it was demonstrated that a polarized redistribution of receptors initiates lymphocyte migration ([@bib72]).

Within the V-SVZ it is the type A neuroblast that starts migrating toward the OB. Our data suggest, however, that cells do not rely on GPER1 for reaching the OB, their final destination, as migratory type A cells do not express this receptor in the RMS. The exit from the cell cycle, which includes proliferation and differentiation, takes place in the neurogenic niche before migration is initiated. The question of how these signals are coordinated during cell fate determination has been extensively studied in progenitor cells in *Drosophila* and *C. elegans*, where cell fate is influenced by asymmetric cell divisions. This also holds true for mammalian cells (for review see [@bib76]), in particular during development of the brain. During brain development the progenitor pool is increased by symmetric cell divisions, whereas subsequent asymmetric divisions in neurogenic niches coordinate self-renewal with differentiation of cells committed to the neuronal lineage ([@bib110]). It was proposed that polarized expression of cellular components underlie asymmetric cell division and thus cell fate and cell positioning ([@bib16], [@bib91], [@bib38], [@bib48]). Regarding the polarized expression of GPER1 in different precursors of the germinal region it could well be that GPER1 expression contributes to these processes.

Astrocytes Are Able to Supply GPER1-Positive Cells in the Germinal Niche and ERα-Positive Cells in the RMS with Estradiol {#sec3.2}
-------------------------------------------------------------------------------------------------------------------------

Since the discovery of aromatase expression in the central nervous system ([@bib71]) its activity was first detected in brain areas that are involved in reproductive functions and behaviors, e.g., the hypothalamus ([@bib32], [@bib85]). However, in the last decade aromatase has been identified in many other brain regions such as the hippocampus, visual cortex, and temporal cortex ([@bib86], [@bib105], [@bib5], [@bib87]). Using immunohistochemistry for aromatase we provide evidence that the last enzyme in estradiol synthesis is expressed by astrocytes, which sheath the cells of the V-SVZ and the migrating precursors in the RMS. Thus locally synthesized estradiol may serve as a ligand for cells expressing E2 receptors. Our data showing expression of aromatase in glial cells are in contrast to previous studies of aromatase expression in the rat OB ([@bib42]), where the enzyme is expressed exclusively in neurons in the main OB. Aromatase-expressing astrocytes, however, were observed in many brain regions under physiological conditions ([@bib49], [@bib105], [@bib106]) and after injury, highlighting the neuroprotective capacities of the enzyme ([@bib35]).

Adult type A cells in the RMS are negative for GPER1 but express the classical genomic receptor ERα. GPER1 immunoreactivity was only seen in type A cells in the V-SVZ and at the beginning of the RMS. This pattern of immunoreactivity strongly suggests that different cells persisting and/or migrating from the V-SVZ exhibit different subsets or combinations of E2 receptors. This different receptor load may enable cells to respond differentially to E2, depending on their developmental stage with regard to migration, cell division, differentiation, and migration. Our finding of aromatase-positive astrocytes in the V-SVZ as well as in the RMS suggests an important role of E2 in the differentiation and migration of V-SVZ-derived cells in the female brain.

GPER1 Is Involved in the Modulation of Cofilin via Ras-Mediated Alteration of p21 Expression {#sec3.3}
--------------------------------------------------------------------------------------------

In the last decade several studies analyzed the effect of GPER1 activation in various cell lines with discrepant results. Some studies showed that GPER1 activation leads to growth inhibition ([@bib18]), whereas others postulated a growth-promoting action of GPER1 activation ([@bib97], [@bib98], [@bib2]). The modulation of cell growth by GPER1 activation is transmitted by modulations of p21 expression ([@bib18]). The cell cycle regulator p21 was originally thought to inhibit cell cycle progression ([@bib1], [@bib28]). The phosphorylated form of p21, however, controls the reorganization of the actin cytoskeleton, which is also required for cell shape alterations and cell migration ([@bib10]). The control of cytoskeleton organization via p21 takes place through inhibition of the ROCK/LIMK/cofilin pathway ([@bib52]). We found in our study a significant reduction of p21 in V-SVZ cultures treated with G15, and this reduction was paralleled by an increase in the ratio of p-cofilin/cofilin. Our data are in line with studies showing that an elevation of p21 levels results in a decrease in the phosphorylation level of cofilin and in turn to polymerization of actin ([@bib52]), which is a prerequisite for cell migration and cell shape alterations. Consequently, cofilin has been shown to be associated with neuronal migration disorders and cell cycle control in the cerebral cortex ([@bib8]). However, it needs to be considered that the V-SVZ is not a static construct. After the exit from the cell cycle, cells need to reorganize their position within the V-SVZ resulting in a permanent modulation of the germinal niche. This is especially important as cells in this region pass through different developmental states (from type B to type C to type A cells) with every cell being positioned in a special region within the germinal niche also depending on their final positioning within the OB ([@bib68], [@bib55]). It has been shown that cofilin is active at the leading edge of locomotory protrusions of migrating cells ([@bib15]). In addition, inhibition of its activity causes defects in protrusion, cell polarity, and chemotaxis ([@bib21], [@bib69], [@bib90]). Hence changes in the p-cofilin/cofilin ratio can influence cell cycle exit decisions as well as the positioning within the germinal niche. In other systems it was shown that E2 via GPER and ER is able to induce neuritogenesis ([@bib22]), which also depends on remodeling of the cytoskeleton. Thus in the V-SVZ polarized GPER1 signaling could be a component influencing differentiation and/or positioning of cells.

In summary, the evidence presented in this study reveals a role of the ER GPER1 in the control of SVZ-derived neuroblast differentiation and migration, by influencing p21 expression and thereby modulating the ratio of p-cofilin/cofilin during development. As the V-SVZ is the biggest region with ongoing neurogenesis in the adult brain, which generates new neurons for the OB throughout life, the mechanism observed during development may also apply for the adult V-SVZ. The activation of the same signaling pathway in distinct V-SVZ-derived cells may induce different biological responses required to control the multiple steps of neurogenesis including progression along the cell line and cell migration in this germinal niche.

Limitations of the Study {#sec3.4}
------------------------

All experiments in this study were carried out on female animals. It is therefore not yet possible to make a cross-gender statement on the function of the examined ER GPER1 in migration of V-SVZ-derived cells.

Methods {#sec5}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Supplemental Information {#appsec2}
========================

Document S1. Transparent Methods and Figures S1--S3
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